181 related articles for article (PubMed ID: 17878478)
1. Phase II study of pentostatin in patients with corticosteroid-refractory chronic graft-versus-host disease.
Jacobsohn DA; Chen AR; Zahurak M; Piantadosi S; Anders V; Bolaños-Meade J; Higman M; Margolis J; Kaup M; Vogelsang GB
J Clin Oncol; 2007 Sep; 25(27):4255-61. PubMed ID: 17878478
[TBL] [Abstract][Full Text] [Related]
2. Pentostatin in steroid-refractory acute graft-versus-host disease.
Bolaños-Meade J; Jacobsohn DA; Margolis J; Ogden A; Wientjes MG; Byrd JC; Lucas DM; Anders V; Phelps M; Grever MR; Vogelsang GB
J Clin Oncol; 2005 Apr; 23(12):2661-8. PubMed ID: 15837980
[TBL] [Abstract][Full Text] [Related]
3. A high-dose pulse steroid regimen for controlling active chronic graft-versus-host disease.
Akpek G; Lee SM; Anders V; Vogelsang GB
Biol Blood Marrow Transplant; 2001; 7(9):495-502. PubMed ID: 11669216
[TBL] [Abstract][Full Text] [Related]
4. Extracorporeal photoimmunotherapy for the treatment of steroid refractory progressive chronic graft-versus-host disease.
Ilhan O; Arat M; Arslan O; Ayyildiz E; Sanli H; Beksac M; Ozcan M; Gürman G; Akan H
Transfus Apher Sci; 2004 Jun; 30(3):185-7. PubMed ID: 15172621
[TBL] [Abstract][Full Text] [Related]
5. An old drug for a new disease: pentostatin (Nipent) in acute graft-versus-host disease.
Margolis J; Vogelsang G
Semin Oncol; 2000 Apr; 27(2 Suppl 5):72-7. PubMed ID: 10877057
[TBL] [Abstract][Full Text] [Related]
6. Chronic graft-versus-host disease: a prospective cohort study.
Arora M; Burns LJ; Davies SM; Macmillan ML; Defor TE; Miller WJ; Weisdorf DJ
Biol Blood Marrow Transplant; 2003 Jan; 9(1):38-45. PubMed ID: 12533740
[TBL] [Abstract][Full Text] [Related]
7. Limited benefit of pentostatin salvage therapy for steroid-refractory grade III-IV acute graft-versus-host disease.
Alam N; Atenafu EG; Tse G; Viswabandya A; Gupta V; Kim D; Lipton JH; Messner HA; Kuruvilla J
Clin Transplant; 2013; 27(6):930-7. PubMed ID: 24304375
[TBL] [Abstract][Full Text] [Related]
8. Pentostatin as rescue therapy for glucocorticoid-refractory acute and chronic graft-versus-host disease.
Pidala J; Kim J; Roman-Diaz J; Shapiro J; Nishihori T; Bookout R; Anasetti C; Kharfan-Dabaja MA
Ann Transplant; 2010; 15(4):21-9. PubMed ID: 21183872
[TBL] [Abstract][Full Text] [Related]
9. Daclizumab for children with corticosteroid refractory graft-versus-host disease.
Teachey DT; Bickert B; Bunin N
Bone Marrow Transplant; 2006 Jan; 37(1):95-9. PubMed ID: 16247417
[TBL] [Abstract][Full Text] [Related]
10. Corticosteroid-Free Primary Treatment of Chronic Extensive Graft-versus-Host Disease Incorporating Rituximab.
Solomon SR; Sizemore CA; Ridgeway M; Zhang X; Smith J; Brown S; Holland HK; Morris LE; Bashey A
Biol Blood Marrow Transplant; 2015 Sep; 21(9):1576-82. PubMed ID: 25985915
[TBL] [Abstract][Full Text] [Related]
11. Long term outcome of patients with steroid-refractory acute intestinal graft versus host disease after treatment with pentostatin.
Klein SA; Bug G; Mousset S; Hofmann WK; Hoelzer D; Martin H
Br J Haematol; 2011 Jul; 154(1):143-6. PubMed ID: 21477160
[No Abstract] [Full Text] [Related]
12. Pulse cyclophosphamide for corticosteroid-refractory graft-versus-host disease.
Mayer J; Krejcí M; Doubek M; Pospísil Z; Brychtová Y; Tomíska M; Rácil Z
Bone Marrow Transplant; 2005 Apr; 35(7):699-705. PubMed ID: 15696180
[TBL] [Abstract][Full Text] [Related]
13. The effect of budesonide mouthwash on oral chronic graft versus host disease.
Sari I; Altuntas F; Kocyigit I; Sisman Y; Eser B; Unal A; Fen T; Ferahbas A; Ozturk A; Unal A; Cetin M
Am J Hematol; 2007 May; 82(5):349-56. PubMed ID: 17109390
[TBL] [Abstract][Full Text] [Related]
14. Prospective study of extracorporeal photopheresis in steroid-refractory or steroid-resistant extensive chronic graft-versus-host disease: analysis of response and survival incorporating prognostic factors.
Foss FM; DiVenuti GM; Chin K; Sprague K; Grodman H; Klein A; Chan G; Stiffler K; Miller KB
Bone Marrow Transplant; 2005 Jun; 35(12):1187-93. PubMed ID: 15852025
[TBL] [Abstract][Full Text] [Related]
15. Sirolimus as part of immunosuppressive therapy for refractory chronic graft-versus-host disease.
Jurado M; Vallejo C; Pérez-Simón JA; Brunet S; Ferra C; Balsalobre P; Pérez-Oteyza J; Espigado I; Romero A; Caballero D; Sierra J; Ribera JM; Díez JL
Biol Blood Marrow Transplant; 2007 Jun; 13(6):701-6. PubMed ID: 17531780
[TBL] [Abstract][Full Text] [Related]
16. Successful treatment of steroid-refractory hepatitic variant of liver graft-vs-host disease with pulse cyclophosphamide.
Mayer J; Krejci M; Pospisil Z; Doubek M; Janikova A; Zackova D; Racil Z; Smardova L; Navratil M; Kamelander J
Exp Hematol; 2009 Jun; 37(6):767-73. PubMed ID: 19463776
[TBL] [Abstract][Full Text] [Related]
17. The role of thalidomide in the treatment of refractory chronic graft-versus-host disease following bone marrow transplantation in children.
Rovelli A; Arrigo C; Nesi F; Balduzzi A; Nicolini B; Locasciulli A; Vassallo E; Miniero R; Uderzo C
Bone Marrow Transplant; 1998 Mar; 21(6):577-81. PubMed ID: 9543061
[TBL] [Abstract][Full Text] [Related]
18. Topical corticosteroid therapy for cicatricial conjunctivitis associated with chronic graft-versus-host disease.
Robinson MR; Lee SS; Rubin BI; Wayne AS; Pavletic SZ; Bishop MR; Childs R; Barrett AJ; Csaky KG
Bone Marrow Transplant; 2004 May; 33(10):1031-5. PubMed ID: 15048138
[TBL] [Abstract][Full Text] [Related]
19. Pentostatin for treatment of steroid-refractory acute GVHD: a retrospective single-center analysis.
Schmitt T; Luft T; Hegenbart U; Tran TH; Ho AD; Dreger P
Bone Marrow Transplant; 2011 Apr; 46(4):580-5. PubMed ID: 20562925
[TBL] [Abstract][Full Text] [Related]
20. Successful prevention of acute graft-versus-host disease using low-dose antithymocyte globulin after mismatched, unrelated, hematopoietic stem cell transplantation for acute myelogenous leukemia.
Kim HJ; Min WS; Cho BS; Eom KS; Kim YJ; Min CK; Lee S; Cho SG; Jin JY; Lee JW; Kim CC
Biol Blood Marrow Transplant; 2009 Jun; 15(6):704-17. PubMed ID: 19450755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
